F18.95 Inhalant use, unspecified with inhalant-induced psychotic disorder

Name of the Condition

• Common Name: Inhalant Use Disorder with Psychotic Features
• Medical Term: Inhalant Use, Unspecified with Inhalant-Induced Psychotic Disorder

Summary

Inhalant use, unspecified with inhalant-induced psychotic disorder is a mental health condition characterized by the misuse of inhalants—substances that produce chemical vapors—and the development of psychosis, which includes delusions or hallucinations. This condition can significantly impact an individual's perception, emotions, and behavior.

Causes

Inhalant use disorder is primarily caused by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household items like glue, paint thinner, or aerosols. Genetic predisposition and environmental factors such as socio-economic challenges or peer pressure can also play a role.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Hallucinations and delusions (psychotic symptoms).
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.

Diagnosis

Clinical evaluation including a detailed history of inhalant use and psychotic symptoms is essential. Physical exams and lab tests may rule out other causes. Diagnostic criteria for inhalant-induced psychotic disorder are applied, considering the temporal relationship between inhalant use and symptom onset.

Treatment Options

Treatment typically involves a combination of psychotherapy, such as cognitive-behavioral therapy, and pharmacotherapy to manage psychotic symptoms. Supportive care, including detoxification and rehabilitation programs, may be necessary. Long-term follow-up is recommended to prevent relapse.

Prognosis and Follow-Up

Prognosis varies depending on the severity of use and psychotic symptoms. Early intervention improves outcomes. Regular follow-up with mental health professionals is crucial to monitor symptoms, adjust treatment, and address any co-occurring disorders.

Complications

• Persistent psychosis or cognitive impairment.
• Respiratory or organ damage from inhalant use.
• Increased risk of accidents or injuries due to impaired judgment.
• Social and occupational dysfunction.

Lifestyle & Prevention

• Avoiding inhalant use and educating others about its risks.
• Seeking healthy coping mechanisms for stress or peer pressure.
• Maintaining a supportive environment with open communication.
• Engaging in regular physical and mental health check-ups.

When to Seek Professional Help

Seek help if experiencing hallucinations, delusions, or uncontrollable inhalant use. Immediate medical attention is needed for severe symptoms like confusion, seizures, or respiratory distress.

Tips for Medical Coders

Document the presence of inhalant-induced psychotic disorder clearly, including symptom onset and relationship to inhalant use. Ensure coding aligns with clinical documentation and guidelines for substance-induced psychotic disorders.